Literature DB >> 18332995

AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement.

J M Henderson1, M Sherman, A Tavill, M Abecassis, G Chejfec, T Gramlich.   

Abstract

Entities:  

Year:  2003        PMID： 18332995      PMCID： PMC2020604          DOI： 10.1080/13651820310015833

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN： 1365-182X            Impact factor:   3.647


× No keyword cloud information.
  13 in total

1.  AJCC/TNM cancer staging, present and future.

Authors:  I D Fleming
Journal:  J Surg Oncol       Date:  2001-08       Impact factor: 3.454

2.  Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program.

Authors:  S Ueno; G Tanabe; K Sako; T Hiwaki; H Hokotate; Y Fukukura; Y Baba; Y Imamura; T Aikou
Journal:  Hepatology       Date:  2001-09       Impact factor: 17.425

Review 3.  Prognostic prediction and treatment strategy in hepatocellular carcinoma.

Authors:  Jordi Bruix; Josep M Llovet
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

4.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Authors:  J Bruix; M Sherman; J M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; J Rodés
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

5.  Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.

Authors:  J M Llovet; J Bustamante; A Castells; R Vilana; M del C Ayuso; M Sala; C Brú; J Rodés; J Bruix
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

6.  Purpose of quality standards for infectious diseases. Infectious Diseases Society of America.

Authors:  P A Gross; T L Barrett; E P Dellinger; P J Krause; W J Martone; J E McGowan; R L Sweet; R P Wenzel
Journal:  Clin Infect Dis       Date:  1994-03       Impact factor: 9.079

7.  A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators.

Authors: 
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

Review 8.  Hepatocellular carcinoma: diagnosis and treatment.

Authors:  Alex S Befeler; Adrian M Di Bisceglie
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

9.  Simplified staging for hepatocellular carcinoma.

Authors:  Jean-Nicolas Vauthey; Gregory Y Lauwers; Nestor F Esnaola; Kim-Anh Do; Jacques Belghiti; Nadeem Mirza; Steven A Curley; Lee M Ellis; Jean-Marc Regimbeau; Asif Rashid; Karen R Cleary; David M Nagorney
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

10.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115
View more
  43 in total

1.  Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system.

Authors:  Albert C Y Chan; Sheung Tat Fan; Ronnie T P Poon; Tan To Cheung; Kenneth S H Chok; See Ching Chan; Chung Mau Lo
Journal:  HPB (Oxford)       Date:  2012-12-02       Impact factor: 3.647

2.  Reassessing hepatocellular carcinoma staging in a changing patient population.

Authors:  Ahmed O Kaseb; Neeraj N Shah; Hesham M Hassabo; Jeffrey S Morris; Lianchun Xiao; Yasmin M Abaza; Khalid Soliman; Ju-Seog Lee; Jean-Nicholas Vauthey; Michael Wallace; Thomas A Aloia; Steven Curley; James L Abbruzzese; Manal M Hassan
Journal:  Oncology       Date:  2014-01-08       Impact factor: 2.935

3.  Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.

Authors:  Jean-Nicolas Vauthey; Elijah Dixon; Eddie K Abdalla; W Scott Helton; Timothy M Pawlik; Bachir Taouli; Antoine Brouquet; Reid B Adams
Journal:  HPB (Oxford)       Date:  2010-06       Impact factor: 3.647

Review 4.  A discussion of serum albumin level in advanced-stage hepatocellular carcinoma: a medical oncologist's perspective.

Authors:  Ozgur Tanriverdi
Journal:  Med Oncol       Date:  2014-10-15       Impact factor: 3.064

5.  Pre-liver transplant biopsy in hepatocellular carcinoma: a potential criterion for exclusion from transplantation?

Authors:  Richard S Young; Mohammed Aldiwani; Abdul R Hakeem; Amit Nair; Ashley Guthrie; Judy Wyatt; Darren Treanor; Gareth Morris-Stiff; Rebecca L Jones; K Rajendra Prasad
Journal:  HPB (Oxford)       Date:  2012-12-27       Impact factor: 3.647

6.  Application of tumor-node-metastasis staging 2002 version in locally advanced hepatocellular carcinoma: is it predictive of surgical outcome?

Authors:  Binkui Li; Yunfei Yuan; Guihua Chen; Liru He; Yaqi Zhang; Jinqing Li; Guohui Li; Wan Yee Lau
Journal:  BMC Cancer       Date:  2010-10-07       Impact factor: 4.430

7.  Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma.

Authors:  Wei-Ju Huang; Yung-Ming Jeng; Hong-Shiee Lai; Fang-Yu Bonnie Sheu; Po-Lin Lai; Ray-Hwang Yuan
Journal:  Langenbecks Arch Surg       Date:  2015-08-07       Impact factor: 3.445

8.  Survival analysis of patients with stage I and II hepatocellular carcinoma after a liver transplantation or liver resection.

Authors:  Ramanathan M Seshadri; Siddesh Besur; David J Niemeyer; Megan Templin; Iain H McKillop; Ryan Z Swan; John B Martinie; Mark W Russo; David A Iannitti
Journal:  HPB (Oxford)       Date:  2014-06-25       Impact factor: 3.647

9.  Comparative performances of staging systems for early hepatocellular carcinoma.

Authors:  Hari Nathan; Gilles Mentha; Hugo P Marques; Lorenzo Capussotti; Pietro Majno; Luca Aldrighetti; Carlo Pulitano; Laura Rubbia-Brandt; Nadia Russolillo; Benjamin Philosophe; Eduardo Barroso; Alessandro Ferrero; Richard D Schulick; Michael A Choti; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2009-08       Impact factor: 3.647

10.  Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Impact of Early Response to 4 Weeks of Treatment.

Authors:  Chen-Chun Lin; Chien-Fu Hung; Wei-Ting Chen; Shi-Ming Lin
Journal:  Liver Cancer       Date:  2015-10-15       Impact factor: 11.740
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.